Brief: Pharmasimple H1 Revenue Up At 14.3 Million Euros
July 30 (Reuters) - PHARMASIMPLE SA ALPHS.PA :
* PUBLISHED H1 REVENUE EUR 14.3 MILLION VERSUS EUR 8.7
MILLION
YEAR AGO
* EXPECTS A RAPID IMPROVEMENT IN ITS GROSS MARGIN
* ANTICIPATES THE ACHIEVEMENT OF A PROFITABLE OPERATION IN
THE
SECOND HALF OF 2019
Source text for Eikon: ID:nACT59654
Further company coverage: ALPHS.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; 48 58 772 0920;))
Recent news on Pharmasimple SA
See all newsBrief: Pharmasimple Says It Received Order To Suspend Stock Consolidation
Brief: Pharmasimple Says Stock Consolidation Approved
Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros
Brief: Pharmasimple Announces Reverse Stock Split
Brief: Pharmasimple: Suspension Of OCA Drawdowns From Oct For At Least 6 Months